Lista de

Parkinson disease
46
"Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein" (2018) Martinez, J.H.;Alaimo, A.;Gorojod, R.M. (...)Kotler, M.L. Molecular and Cellular Neuroscience. 88:107-117
"Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein" (2018) Martinez, J.H.;Alaimo, A.;Gorojod, R.M. (...)Kotler, M.L. Molecular and Cellular Neuroscience. 88:107-117
"Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling" (2016) Lemos, J.C.;Friend, D.M.;Kaplan, A.R. (...)Alvarez, V.A. Neuron. 90(4):824-838
"Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling" (2016) Lemos, J.C.;Friend, D.M.;Kaplan, A.R. (...)Alvarez, V.A. Neuron. 90(4):824-838
"How language flows when movements don't: An automated analysis of spontaneous discourse in Parkinson's disease" (2016) García, A.M.;Carrillo, F.;Orozco-Arroyave, J.R. (...)Cecchi, G.A. Brain and Language. 162:19-28
"How language flows when movements don't: An automated analysis of spontaneous discourse in Parkinson's disease" (2016) García, A.M.;Carrillo, F.;Orozco-Arroyave, J.R. (...)Cecchi, G.A. Brain and Language. 162:19-28
"How language flows when movements don't: An automated analysis of spontaneous discourse in Parkinson's disease" (2016) García, A.M.;Carrillo, F.;Orozco-Arroyave, J.R. (...)Cecchi, G.A. Brain and Language. 162:19-28
"Implications of gamma band activity in the pedunculopontine nucleus" (2016) Garcia-Rill, E.;Luster, B.;D’Onofrio, S. (...)Urbano, F.J. Journal of Neural Transmission. 123(7):655-665
"Pedunculopontine arousal system physiology - Deep brain stimulation (DBS)" (2015) Garcia-Rill, E.;Luster, B.;D'Onofrio, S. (...)Urbano, F.J. Sleep Science. 8(3):153-161
"Pedunculopontine arousal system physiology—implications for schizophrenia" (2015) Garcia-Rilla, E.;D’onofrioa, S.;Mahaffeya, S. (...)Urbanob, F.J. Sleep Science. 8(2):82-91
"Mesenchymal stem cells and their use in therapy: What has been achieved?" (2013) Fernández Vallone, V.B.;Romaniuk, M.A.;Choi, H. (...)Chasseing, N.A. Differentiation. 85(1-2):1-10
"Influence of gold nanoparticles on the kinetics of α-synuclein aggregation" (2013) Álvarez, Y.D.;Fauerbach, J.A.;Pellegrotti, J.V. (...)Stefani, F.D. Nano Letters. 13(12):6156-6163
"Influence of gold nanoparticles on the kinetics of α-synuclein aggregation" (2013) Álvarez, Y.D.;Fauerbach, J.A.;Pellegrotti, J.V. (...)Stefani, F.D. Nano Letters. 13(12):6156-6163
"Confocal fluorescence anisotropy and FRAP imaging of α-synuclein amyloid aggregates in living cells" (2011) Roberti, M.J.; Jovin, T.M.; Jares-Erijman, E. PLoS ONE. 6(8)
"Neuroprotective actions of estradiol revisited" (2011) Azcoitia, I.; Arevalo, M.-A.; De Nicola, A.F.; Garcia-Segura, L.M. Trends in Endocrinology and Metabolism. 22(12):467-473
"Quantum dots as ultrasensitive nanoactuators and sensors of amyloid aggregation in live cells" (2009) Roberti, M.J.;Morgan, M.;Menéndez, G. (...)Jares-Erijman, E.A. Journal of the American Chemical Society. 131(23):8102-8107
"Multiparametric Fluorescence Detection of Early Stages in the Amyloid Protein Aggregation of Pyrene-labeled α-Synuclein" (2008) Thirunavukkuarasu, S.; Jares-Erijman, E.A.; Jovin, T.M. Journal of Molecular Biology. 378(5):1064-1073
"Multiparametric Fluorescence Detection of Early Stages in the Amyloid Protein Aggregation of Pyrene-labeled α-Synuclein" (2008) Thirunavukkuarasu, S.; Jares-Erijman, E.A.; Jovin, T.M. Journal of Molecular Biology. 378(5):1064-1073
"Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged α-synuclein" (2007) Roberti, M.J.;Bertoncini, C.W.;Klement, R. (...)Jovin, T.M. Nature Methods. 4(4):345-351
"Multiple sclerosis. Old observations, new hypotheses, future perspectives " (2005) Correale, J.; Carrea, R. Medicina. 65(2):175-180
"NMR of α-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation" (2004) Fernández, C.O.;Hoyer, W.;Zweckstetter, M. (...)Jovin, T.M. EMBO Journal. 23(10):2039-2046
"NMR of α-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation" (2004) Fernández, C.O.;Hoyer, W.;Zweckstetter, M. (...)Jovin, T.M. EMBO Journal. 23(10):2039-2046
"Delayed intracerebral electrode infection after bilateral STN implantation for parkinson's disease" (2001) Merello, M.; Cammarota, A.; Leiguarda, R.; Pikielny, R. Movement Disorders. 16(1):168-170
"Delayed intracerebral electrode infection after bilateral STN implantation for parkinson's disease" (2001) Merello, M.; Cammarota, A.; Leiguarda, R.; Pikielny, R. Movement Disorders. 16(1):168-170
"Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation" (2001) Merello, M.;Starkstein, S.;Nouzeilles, M.I. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 71(5):611-614
"Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation" (2001) Merello, M.;Starkstein, S.;Nouzeilles, M.I. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 71(5):611-614
"Parkinson's disease is associated with oxidative stress: Comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients" (2001) Serra, J.A.;Domínguez, R.O.;De Lustig, E.S. (...)Marschoff, E.R. Journal of Neural Transmission. 108(10):1135-1148
"Parkinson's disease is associated with oxidative stress: Comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients" (2001) Serra, J.A.;Domínguez, R.O.;De Lustig, E.S. (...)Marschoff, E.R. Journal of Neural Transmission. 108(10):1135-1148
"Comparison of the determination of superoxide dismutase and antioxidant capacity in neurological patients using two different procedures" (2000) Serra, J.A.;Marschoff, E.R.;Domínguez, R.O. (...)Guareschi, E.M. Clinica Chimica Acta. 301(1-2):87-102
"Comparison of the determination of superoxide dismutase and antioxidant capacity in neurological patients using two different procedures" (2000) Serra, J.A.;Marschoff, E.R.;Domínguez, R.O. (...)Guareschi, E.M. Clinica Chimica Acta. 301(1-2):87-102
"The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice" (2000) Murer, M.G.;Dziewczapolski, G.;Salin, P. (...)Gershanik, O. Neuroscience. 99(4):643-650
"The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice" (2000) Murer, M.G.;Dziewczapolski, G.;Salin, P. (...)Gershanik, O. Neuroscience. 99(4):643-650
"Effect of memantine (NMDA antagonist) on Parkinson's disease: A double- blind crossover randomized study" (1999) Merello, M.; Nouzeilles, M.I.; Cammarota, A.; Leiguarda, R. Clinical Neuropharmacology. 22(5):273-276
"Effect of memantine (NMDA antagonist) on Parkinson's disease: A double- blind crossover randomized study" (1999) Merello, M.; Nouzeilles, M.I.; Cammarota, A.; Leiguarda, R. Clinical Neuropharmacology. 22(5):273-276
"Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia" (1999) Kuzis, G.;Sabe, L.;Tiberti, C. (...)Starkstein, S.E. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 12(4):265-269
"Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia" (1999) Kuzis, G.;Sabe, L.;Tiberti, C. (...)Starkstein, S.E. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 12(4):265-269
"Cognitive functions in major depression and Parkinson disease" (1997) Kuzis, G.;Sabe, L.;Tiberti, C. (...)Starkstein, S.E. Archives of Neurology. 54(8):982-986
"Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia" (1996) Starkstem, S.E.;Sabe, L.;Petracca, G. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 61(4):381-387
"Catatonia in depression: Prevalence, clinical correlates, and validation of a scale" (1996) Starkstein, S.E.;Petracca, G.;Tesón, A. (...)Leiguarda, R. Journal of Neurology Neurosurgery and Psychiatry. 60(3):326-332
"Adynamic bowel syndrome in Parkinson's disease with dramatic response to apomorphine" (1994) Merello, M.; Leiguarda, R. Clinical Neuropharmacology. 17(6):574-577